Medplus' subsidiary Optival Health Solutions received two suspension orders for drug licenses in Karnataka, one for two days and another for one day, resulting in potential revenue losses of Rs 0.28 lacs and Rs 0.78 lacs respectively, with the orders dated August 25, 2025.